Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
De-escalation therapy in ventilator-associated pneumonia.
Rello J, Vidaur L, Sandiumenge A, Rodríguez A, Gualis B, Boque C, Diaz E. Rello J, et al. Among authors: boque c. Crit Care Med. 2004 Nov;32(11):2183-90. doi: 10.1097/01.ccm.0000145997.10438.28. Crit Care Med. 2004. PMID: 15640629
Troponin elevation in patients without acute coronary syndrome.
Bardají A, Cediel G, Carrasquer A, de Castro R, Sánchez R, Boqué C. Bardají A, et al. Among authors: boque c. Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):469-76. doi: 10.1016/j.rec.2014.10.018. Epub 2015 Mar 21. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25800165
Home care/outpatient versus hospital admission in mild acute pancreatitis: protocol of a multicentre, randomised controlled trial (PADI_2 trial).
Ramírez-Maldonado E, Rodrigo-Rodrigo M, Lopez Gordo S, Sanchez A, Coronado Llanos D, Sanchez R, Vaz J, Fondevila C, Jorba-Martin R; Catalan Pancreatitis Collaborative Group. Ramírez-Maldonado E, et al. BMJ Open. 2023 Jun 28;13(6):e071265. doi: 10.1136/bmjopen-2022-071265. BMJ Open. 2023. PMID: 37380212 Free PMC article.
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors.
Pérez-Lamas L, Luna A, Boque C, Xicoy B, Giraldo P, Pérez López R, Ruiz Nuño C, De Las Heras N, Mora Casterá E, López Marín J, Segura Díaz A, Gómez V, Vélez Tenza P, Sierra Pacho M, Vera Goñi JA, Moreno Vega M, Alvarez-Larrán A, Cortés M, Pérez Encinas M, Carrascosa Mastell P, Angona A, Rosell A, Lakhwani S, Colorado M, Ramila E, Cervero C, Cuevas B, Villalón Blanco L, de Paz R, Paz Coll A, Fernández MJ, Felipe Casado L, Alonso-Domínguez JM, Anguita Arance MM, Salamanca Cuenca A, Jiménez-Velasco A, Prendes SO, Santaliestra M, Lis Chulvi MJ, Hernández-Boluda JC, García-Gutiérrez V. Pérez-Lamas L, et al. Among authors: boque c. Cancers (Basel). 2023 Feb 7;15(4):1045. doi: 10.3390/cancers15041045. Cancers (Basel). 2023. PMID: 36831388 Free PMC article.
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients.
Estrada N, Zamora L, Ferrer-Marín F, Palomo L, García O, Vélez P, De la Fuente I, Sagüés M, Cabezón M, Cortés M, Vallansot RO, Senín-Magán MA, Boqué C, Xicoy B. Estrada N, et al. Among authors: boque c. J Clin Med. 2022 Oct 21;11(20):6217. doi: 10.3390/jcm11206217. J Clin Med. 2022. PMID: 36294538 Free PMC article.
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia.
Luna A, Pérez-Lamas L, Boque C, Giraldo P, Xicoy B, Ruiz Nuño C, Vega MM, Alvarez-Larrán A, Salamanca A, García-Noblejas A, Vall-Llovera F, Villalon L, De Las Heras N, Ramila E, Pérez-Encinas M, Cuevas B, Perez-Lopez R, Sanchez-Guijo F, Jiménez-Velasco A, Lakhwani S, Casado LF, Rosell A, Escola A, Fernández MJ, Garcia-Hernandez C, Cervero C, Mora E, Sagüés M, Suarez-Varela S, Vélez P, Carrascosa Mastell P, Bitaube RF, Serrano L, Cortes M, Vera Goñi JA, Steegmann JL, de Soria VGG, Alonso-Dominguez JM, Araujo MC, Coll AP, Hernandez-Boluda JC, García-Gutiérrez V. Luna A, et al. Among authors: boque c. Ann Hematol. 2022 Oct;101(10):2263-2270. doi: 10.1007/s00277-022-04932-6. Epub 2022 Aug 23. Ann Hematol. 2022. PMID: 35997804 Free PMC article.
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
Reverté L, Yeregui E, Olona M, Gutiérrez-Valencia A, Buzón MJ, Martí A, Gómez-Bertomeu F, Auguet T, López-Cortés LF, Burgos J, Benavent-Bofill C, Boqué C, García-Pardo G, Ruiz-Mateos E, Mestre MT, Vidal F, Viladés C, Peraire J, Rull A; COVIDOMICS Study Group. Reverté L, et al. Among authors: boque c. Clin Transl Med. 2022 Jan;12(1):e704. doi: 10.1002/ctm2.704. Clin Transl Med. 2022. PMID: 35075803 Free PMC article. No abstract available.
Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients.
Estrada N, Xicoy B, Beier F, Garcia O, Morales C, Boqué C, Sagüés M, Ventura Ferreira MS, Vallansot R, Marcé S, Cabezón M, Brümmendorf TH, Zamora L. Estrada N, et al. Among authors: boque c. Hemasphere. 2021 Nov 30;5(12):e657. doi: 10.1097/HS9.0000000000000657. eCollection 2021 Dec. Hemasphere. 2021. PMID: 34853825 Free PMC article.
66 results